dasatinib NDC 70710-1745

NDC codes

FDA NDC Directory

Product NDC (as listed)70710-1745Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70710-1745Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70710-1745-3	70710174503	30 TABLET in 1 BOTTLE (70710-1745-3)Marketed from Mar 3, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): dasatinib
Generic name (nonproprietary): dasatinib
Active ingredients: Dasatinib — 100 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Zydus Pharmaceuticals USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218719
Marketing start: Mar 3, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Cytochrome P450 3A4 Inhibitors (Mechanism)Protein Kinase Inhibitors (Mechanism)
Identifiers: Product ID 70710-1745_46121457-8af5-4016-827f-ead2f0b33b83SPL ID 46121457-8af5-4016-827f-ead2f0b33b83SPL set ID 11703145-29ea-480a-9810-bc70663b783fRxCUI 643105, 643107, 643109, 799047, 1045402, 1045406UNII RBZ1571X5HUPC 0370710174361, 0370710174163, 0370710174262
Pharmacologic class: Kinase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470710174503 followed by a unit qualifier and the quantity

Package 70710-1745-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 218719

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218719
Product	Strength	Form · route	Labeler	Product NDC
dasatinib	Dasatinib 70 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1903
dasatinib	Dasatinib 20 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1901
dasatinib	Dasatinib 50 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1902
dasatinib	Dasatinib 70 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1743
dasatinib	Dasatinib 80 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1904
dasatinib	Dasatinib 100 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1905
dasatinib	Dasatinib 20 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1741
dasatinib	Dasatinib 140 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1906
dasatinib	Dasatinib 50 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1742
dasatinib	Dasatinib 140 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1746
dasatinib	Dasatinib 80 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1744